Evidence supporting the initiation of HPV vaccination starting at age 9: Collection overview

References

• Rosenblum H, Lewis R, Gargano JW, Querec TD, Unger ER, Markowitz LE. Human papillomavirus (HPV) vaccine impact an d effectiveness through twelve years after vaccine introduction in the United States—national health and nutrition examination survey, 2003–2018. Ann Intern Med.
   Google Scholar
• Arbyn M, Bryant A, Beutels P. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev. 2011;2011(4): CD009069. doi:10.1002/14651858.CD009069.
   PubMedGoogle Scholar
• Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, Sundström K, Dillner J, Sparén P. HPV vaccination and the risk of invasive cervical cancer. N Engl J Med. 2020;383(14):1340–4. doi:10.1056/NEJMoa1917338.
   PubMed Web of Science ®Google Scholar
• Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, Izurieta HS, Ball R, Miller N, Braun MM, et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. Jama. 2009;302(7):750–7. doi:10.1001/jama.2009.1201.
   PubMed Web of Science ®Google Scholar
• Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J, Curtis CR, Markowitz L. Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014 - United States. MMWR Morb Mortal Wkly Rep. 2014;63(29):620–4. doi:mm6329a3[pii].
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, Bocchini Jr JA, Unger ER. Human papillomavirus vaccination: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2014;63(RR–05):1–30.
   PubMed Web of Science ®Google Scholar
• Pingali C, Yankey D, Elam-Evans LD, Markowitz LE, Valier MR, Fredua B, Crowe SJ, Stokley S, Singleton JA. National vaccination coverage among adolescents aged 13–17 years — national immunization survey-teen, United States, 2021. MMWR Morb Mortal Wkly Rep. 2022;71(35):1101–8. doi:10.15585/mmwr.mm7135a1.
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics Committee on. Why AAP recommends initiating HPV vaccination as early as age 9; Published online 2019 [accessed 2022 Sept 28]. https://publications.aap.org/aapnews/news/14942?autologincheck=redirected?nfToken=00000000-0000-0000-0000-000000000000.
   Google Scholar
• American Cancer Society. ACS updates HPV vaccination recommendations to start at age 9; Published online 2020. [accessed 2022 Sept 28]. https://www.cancer.org/latest-news/acs-updates-hpv-vaccination-recommendations-to-start-at-age-9.html.
   Google Scholar
• Bednarczyk RA, Brandt HM. Descriptive epidemiology of age at HPV vaccination: analysis using the 2020 NIS-Teen. Hum Vaccin Immunother. 2023;19(1):2204784. doi:10.1080/21645515.2023.2204784.
   PubMed Web of Science ®Google Scholar
• Minihan AK, Bandi P, Star J, Fisher-Borne M, Saslow D, Jemal A. The association of initiating HPV vaccination at ages 9–10 years and up-to-date status among adolescents ages 13–17 years, 2016-2020. Hum Vaccin Immunother. 2023;19(1):2175555. doi:10.1080/21645515.2023.2175555.
   PubMed Web of Science ®Google Scholar
• Kajtezovic S, Morgan JR, Fiascone S, Brandt HM, Perkins RB. Optimizing timing of adolescent vaccines: impact of initiating HPV vaccination before Tdap or meningococcal vaccination on timely completion of the HPV vaccine series. Hum Vaccin Immunother. 2023;19(1):2175541. doi:10.1080/21645515.2023.2175541.
   PubMed Web of Science ®Google Scholar
• Saxena K, Kathe N, Sardana P, Yao L, Chen YT, Brewer NT. HPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US. Hum Vaccin Immunother. 2023;19(1):2161253. doi:10.1080/21645515.2022.2161253.
   PubMed Web of Science ®Google Scholar
• Goodman E, Felsher M, Wang D, Yao L, Chen YT. Early initiation of HPV vaccination and series completion in early and mid-adolescence. Pediatrics. 2023;151(3):e2022058794. doi:10.1542/peds.2022-058794.
   PubMed Web of Science ®Google Scholar
• Ellingson MK, Sheikha H, Nyhan K, Oliveira CR, Niccolai LM. Human papillomavirus vaccine effectiveness by age at vaccination: a systematic review. Hum Vaccin Immunother. 2023;19(2):2239085. doi:10.1080/21645515.2023.2239085.
   PubMed Web of Science ®Google Scholar
• Bhatla N, Muwonge R, Malvi SG, Joshi S, Poli URR, Lucas E, Esmy PO, Verma Y, Shah A, Zomawia E, et al. Impact of age at vaccination, marital status, and cervical HPV infection on binding and neutralizing antibody titers 10 years post-vaccination in recipients of single and higher doses of quadrivalent HPV vaccine.
   Google Scholar
• Joshi S, Anantharaman D, Muwonge R, Bhatla N, Panicker G, Butt J, Rani Reddy Poli U, Malvi SG, Esmy PO, Lucas E, et al. Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination. Vaccine. 2023;41(1):236–45. doi:10.1016/j.vaccine.2022.11.044.
   PubMed Web of Science ®Google Scholar
• Perkins RB, Legler A, Jansen E, Bernstein J, Pierre-Joseph N, Eun TJ, Biancarelli DL, Schuch TJ, Leschly K, Fenton ATHR, et al. Improving HPV vaccination rates: a stepped-wedge randomized trial. Pediatrics. 2020;146(1). doi:10.1542/peds.2019-2737.
   PubMed Web of Science ®Google Scholar
• Dixon BE, Zimet GD, Xiao S, Tu W, Lindsay B, Church A, Downs SM. An educational intervention to improve HPV vaccination: a cluster randomized trial. Pediatrics. 2019;143(1):e20181457. doi:10.1542/peds.2018-1457.
   PubMed Web of Science ®Google Scholar
• Brewer NT, Hall ME, Malo TL, Gilkey MB, Quinn B, Lathren C. Announcements versus conversations to improve HPV vaccination coverage: a randomized trial. Pediatrics. 2017;139(1). doi:10.1542/peds.2016-1764.
   PubMed Web of Science ®Google Scholar
• Zorn S, Darville - Sanders G, Vu T, Carter, A, Treend, K, Raunio, C, Vasavada, A. Multi-level quality improvement strategies to optimize HPV vaccination starting at the 9-year well child visit: success stories from two private pediatric clinics. Hum Vaccines Immunother. 2023;19(1):2163807. doi:10.1080/21645515.2022.2163807.
   PubMed Web of Science ®Google Scholar
• Christensen T, Zorn S, Bay K, Treend K, Averette C, Rhodes N. Effect of immunization registry-based provider reminder to initiate HPV vaccination at age 9, Washington state. Hum Vaccin Immunother.
   Web of Science ®Google Scholar
• O’Leary SC, Frost HM. Does HPV vaccination initiation at age 9, improve HPV initiation and vaccine series completion rates by age 13? Hum Vaccin Immunother. 2023;19(1):2180971. doi:10.1080/21645515.2023.2180971.
   PubMed Web of Science ®Google Scholar
• Rodriguez AM, Do TQN, Chen L, Schmeler KM, Montealegre JR, Kuo YF. Human papillomavirus vaccinations at recommended ages: how a middle school-based educational and vaccination program increased uptake in the Rio Grande Valley. Hum Vaccin Immunother. 2022;18(6):2133315. doi:10.1080/21645515.2022.2133315.
   PubMed Web of Science ®Google Scholar
• Aragones A, Gany F, Kaplan A, Bruno D. An opportunity to increase human papillomavirus vaccination rates: change the guidelines. Hum Vaccin Immunother. 2022;18(6):2136444. doi:10.1080/21645515.2022.2136444.
   PubMed Web of Science ®Google Scholar
• Kohler RE, Wagner RB, Careaga K, Btoush R, Greene K, Kantor L. Mothers’ perceptions and attitudes about HPV vaccination initiation among 9 and 10-year-olds. Hum Vaccin Immunother.
   Web of Science ®Google Scholar
• Foley S, Nkonga J, Fisher-Borne M. Engaging health plans to prioritize HPV vaccination and initiate at age 9. Hum Vaccin Immunother. 2023;19(1):2167906. doi:10.1080/21645515.2023.2167906.
   PubMed Web of Science ®Google Scholar
• Isher-Witt J, Foley S, Hassan A, Sloan A, Nkonga J, Fisher-Borne M. Age nine is possible: improving age 9 HPV initiation through a national quality improvement initiative during the COVID-19 pandemic.
   Google Scholar
• O’Leary ST. Why the American academy of pediatrics recommends initiating HPV vaccine at age 9. Hum Vaccin Immunother. 2022;18(6):2146434. doi:10.1080/21645515.2022.2146434.
   PubMed Web of Science ®Google Scholar
• Lake P, Fuzzell L, Brownstein NC, Fontenot HB, Michel A, McIntyre M, Whitmer A, Rossi SL, Perkins RB, Vadaparampil ST, et al. HPV vaccine recommendations by age: a survey of providers in federally qualified health centers. Hum Vaccin Immunother. 2023;19(1):2181610. doi:10.1080/21645515.2023.2181610.
   PubMed Web of Science ®Google Scholar
• Kahn JA, Rosenthal SL, Tissot AM, Bernstein DI, Wetzel C, Zimet GD. Factors influencing pediatricians’ intention to recommend human papillomavirus vaccines. Ambul Pediatr. 2007;7(5):367–73. doi:10.1016/j.ambp.2007.05.010.
   PubMedGoogle Scholar
• Brewer NT, Kahn BZ, Kritikos KI, Heisler-MacKinnon JA, Young JD, Gilkey MB. How to make effective HPV vaccine recommendations starting at age 9. Hum Vaccin Immunother. 2023;19(2):2216117. doi:10.1080/21645515.2023.2216117.
   PubMed Web of Science ®Google Scholar
• Bednarczyk RA, Brewer NT, Gilkey MB, Zorn, S, Perkins, RB, Oliver, K, Saslow, D. Human papillomavirus vaccination at the first opportunity: an overview. Hum Vaccin Immunother. 2023;19(1):2213603. doi:10.1080/21645515.2023.2213603.
   PubMed Web of Science ®Google Scholar
• Coyne-Beasley T, Ortiz RR. Recommending HPV vaccination at age 9 to reduce health disparities: communication challenges and opportunities. Hum Vaccin Immunother. 2023;19(1):2178219. doi:10.1080/21645515.2023.2178219.
   PubMed Web of Science ®Google Scholar
• Brandt HM, Footman A, Adsul P, Ramanadhan S, Kepka D. Implementing interventions to start HPV vaccination at age 9: using the evidence we have. Hum Vaccin Immunother. 2023;19(1):2180250. doi:10.1080/21645515.2023.2180250.
   PubMed Web of Science ®Google Scholar